Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Pheochromocytoma × 6-fluorodopamine × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1 CNS 1

Conditions

Pheochromocytoma 1 Neuroblastoma 1

Interventions

Specimen Handling 3 Temozolomide 2 Magnetic Resonance Spectroscopy 2 tipifarnib 1 talazoparib 1 olaparib 1 lutetium Lu 177 dotatate 1 lanreotide 1 copper dotatate CU-64 1 Staining and Labeling 1 Nivolumab 1 Lutetium-177 1 Lutetium 1 Ipilimumab 1 Contrast Media 1 CTLA-4 Antigen 1 Biopsy 1 6-fluorodopamine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03541720 2025-12-03

18F-Fluorodopamine PET Studies of Neuroblastoma and Pheochromocytoma

St. Jude Children's Research Hospital

Phase EARLY_PHASE1 Active not recruiting

Neuroblastoma, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡